| abstract |
The invention relates to tetrahydro-pyrido [3,4-b] indol-1-yl compounds having estrogen receptor modulating activity or function, said compounds having a structure of formula (i), as well as stereoisomers, tautomers or pharmaceutically acceptable salts thereof, and their substituents and structural characteristics. The present invention also relates to pharmaceutical compositions and medicaments containing said compounds of formula (i), as well as to methods of using said estrogen receptor modulators, alone or in combination with other therapeutic agents, in the treatment of diseases. or disorders induced or dependent on estrogen receptors. |